Zepbound (tirzepatide)

Zepbound is tirzepatide licensed for weight management — the same molecule as Mounjaro®, under a different label. It also carries an approval for obstructive sleep apnoea in people with obesity, which is the first indication of its kind in this class.

How it works

It acts on the GLP-1 receptor and, unusually in this class, also on the receptor for a second gut hormone — glucose-dependent insulinotropic polypeptide, or GIP. Activating that receptor does three things at once: it amplifies insulin release when blood glucose is high, it slows the rate at which the stomach empties, and it changes appetite signalling in the brain.

Those three actions explain almost everything about the experience of taking it. The metabolic benefit comes from the first; the sense of eating less without deciding to comes from the third; and most of the side effects are the second one felt from the inside. The mechanism in full is here.

What sets it apart

Zepbound is a United States product. In Europe and much of the rest of the world, tirzepatide for weight management is prescribed as Mounjaro® instead — which is why guidance written for a US audience often names a product that does not exist in your pharmacy.

Who it is for

Zepbound is licensed for chronic weight management; obstructive sleep apnoea in obesity. That licence is not a formality: it determines what your prescriber can lawfully prescribe it for, what a health system or insurer will fund, and which dose ceiling applies. Two products containing the same molecule can carry different licences, and that is usually the real difference between them.

Whether it suits you is a separate question, and one that depends on your medical history rather than on the product. The exclusions that come up most often are a personal or family history of medullary thyroid carcinoma or MEN 2, a history of pancreatitis, pregnancy or planned pregnancy, and severe gastrointestinal disease. None of these can be assessed from a web page — they are the reason the first conversation happens with a clinician.

The dose ladder

Treatment starts below a working dose and climbs on a schedule. The starting dose is not a treatment dose — it exists so the gut can adapt.

Maintenance: 5 mg, 10 mg or 15 mg weekly. The full schedule, with what each rung is for, is here.

What the first months look like

Zepbound reaches a stable blood level in about 25 days, which is why the early weeks so often feel like nothing is happening. They are not a failure of the medicine; they are the medicine still arriving.

• Month one. Blood levels climbing toward their plateau on a starting dose that is not expected to do much. Side effects, if they appear, cluster in the days after each increase.
• Months two and three. The first genuinely therapeutic doses. This is usually where appetite change becomes unmistakable rather than ambiguous.
• Beyond. Either continued escalation or settling at a dose that works. Both are legitimate destinations; the top of the ladder is a ceiling, not a target.

Side effects, in outline

Identical to Mounjaro®, because it is the same molecule on the same escalation ladder. Any difference people report between the two is a difference in the population taking them, not in the drug. The common effects — nausea, early fullness, constipation, reflux and fatigue — trace back to a stomach emptying more slowly, and they follow the dose ladder rather than appearing at random. The full picture, including the symptoms that are not side effects to wait out, is here.

Taking it

Once weekly, any day, with or without food. Single-dose pen or vial. Available strengths: 2.5, 5, 7.5, 10, 12.5 and 15 mg.

Because it is taken weekly, the routine that matters most is consistency — a fixed time you can keep to, and a way of recording that you did. The step-by-step routine is here, and the rule for a late dose is here.

Storage, in brief

Unopened: 2–8 °C. Once in use: 21 days (US label) at up to 30 °C. Two clocks run — the printed expiry on an unopened product, and the in-use window that starts at first use and does not reset if the product goes back in the fridge. The detail, including travel, is here.

Stopping

Because Zepbound clears over about 25 days rather than overnight, stopping is a gradual process whether or not you intend it to be. Appetite returns along that curve, which most people describe as something that crept up over weeks rather than an event.

That slow return is worth planning for. The window in which appetite is coming back but is not yet fully back is the window in which habits either hold or do not — and it is a much better time to have a plan than to improvise one. Stopping is also a decision to make with your prescriber rather than unilaterally, particularly where the medicine is treating diabetes rather than weight.

What it does not do

• It does not burn fat. There is no metabolic furnace being switched on. Weight changes because intake falls.
• It does not choose what you lose. Weight lost quickly, on low protein and without resistance training, includes a meaningful share of lean tissue. This is the most consequential under-discussed part of the treatment.
• It does not permanently retrain appetite. The effect is a response to a signal, and the signal stops when the medicine does.

How it compares

• Mounjaro vs Zepbound — Same molecule, same ladder, different label and different geography.
• Wegovy vs Zepbound — The two weight-management flagships.

Zepbound in detail

Common questions about Zepbound

Is Zepbound dosed the same as Mounjaro?

Yes — identical molecule, identical ladder, identical increments. The difference between the two products is the licence and the market, not the schedule.

Does Zepbound have different side effects from Mounjaro?

No. Same molecule, same ladder, same profile. Differences people report between the two reflect the populations taking them, not the drug.

How late can I take a Zepbound dose?

Up to four days after the scheduled day, with at least three days before the next one. Beyond that, skip it and resume on your usual day.

Is Zepbound stored like Mounjaro?

Yes — refrigerated before first use, with a limited room-temperature window afterwards. Check your own leaflet for the figure that applies to your product and region.

Can I get Zepbound outside the United States?

Generally not under that name. In Europe and much of the rest of the world, tirzepatide for weight management is prescribed as Mounjaro®. Guidance written for a US audience often names a product that does not exist in your pharmacy.